A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer
- PMID: 31580491
- DOI: 10.1002/cncr.32342
A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer
Abstract
Background: Racial disparities in squamous cell carcinoma of the head and neck (HNSCC) negatively affect non-Hispanic black (NHB) patients. This study was aimed at understanding how treatment is prescribed and received across all HNSCC subsites.
Methods: With the National Cancer Database, patients from 2004 to 2014 with surgically resectable HNSCCs, including tumors of the oral cavity (OC), oropharynx (OP), hypopharynx (HP), and larynx (LX), were studied. The treatment received was either upfront surgery or nonsurgical treatment. Treatment patterns were compared according to race and subsite, and how these differences changed over time was evaluated.
Results: NHB patients were less likely than non-Hispanic white (NHW) patients to receive surgery across all subsites (relative risk [RR] for OC, 0.87; RR for OP, 0.75; RR for HP, 0.73; RR for LX, 0.87; all P values <.05). They were also more likely to refuse a recommended surgery (RR for OC, 1.50; RR for OP, 1.23; RR for HP, 1.23; RR for LX, 1.34), and this difference was significant except for HP. NHB patients were more likely to not be offered surgery across all subsites (RR for OC, 1.38; RR for OP, 1.07; RR for HP, 1.05; RR for LX, 1.03; all P values <.05). Rates of surgery increased and rates of not being offered surgery declined for both NHB and NHW patients from 2004 to 2014, but the absolute disparities persisted in 2014.
Conclusions: Across all HNSCC subsites, NHB patients were less likely than NHW patients to be recommended for and receive surgery and were more likely to refuse surgery. These differences have closed over time but persist. Enhanced shared decision making may improve these disparities.
Keywords: head and neck neoplasms; health care disparities; race factors.
© 2019 American Cancer Society.
Similar articles
-
Explaining Racial Disparities in Surgically Treated Head and Neck Cancer.Laryngoscope. 2021 May;131(5):1053-1059. doi: 10.1002/lary.29197. Epub 2020 Oct 27. Laryngoscope. 2021. PMID: 33107610
-
Racial disparities in the choice of definitive treatment for squamous cell carcinoma of the oral cavity.Head Neck. 2018 Nov;40(11):2372-2382. doi: 10.1002/hed.25341. Epub 2018 Jun 26. Head Neck. 2018. PMID: 29947066 Free PMC article.
-
Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities.Head Neck. 2011 Jan;33(1):45-53. doi: 10.1002/hed.21398. Head Neck. 2011. PMID: 20848419 Free PMC article.
-
Pediatric non-nasopharyngeal head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results (SEER) program with review of the literature.Int J Pediatr Otorhinolaryngol. 2024 Nov;186:112135. doi: 10.1016/j.ijporl.2024.112135. Epub 2024 Oct 15. Int J Pediatr Otorhinolaryngol. 2024. PMID: 39442194 Review.
-
Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.Eur Arch Otorhinolaryngol. 2019 Mar;276(3):647-655. doi: 10.1007/s00405-019-05292-0. Epub 2019 Jan 23. Eur Arch Otorhinolaryngol. 2019. PMID: 30673847
Cited by
-
Factors Associated with Head and Neck Cancer Postoperative Radiotherapy Delays: A Systematic Review and Meta-analysis.Otolaryngol Head Neck Surg. 2024 Nov;171(5):1265-1282. doi: 10.1002/ohn.835. Epub 2024 Jun 6. Otolaryngol Head Neck Surg. 2024. PMID: 38842034
-
HSD17B7 gene in self-renewal and oncogenicity of keratinocytes from Black versus White populations.EMBO Mol Med. 2021 Jul 7;13(7):e14133. doi: 10.15252/emmm.202114133. Epub 2021 Jun 29. EMBO Mol Med. 2021. PMID: 34185380 Free PMC article.
-
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity.Curr Oncol Rep. 2022 Sep;24(9):1153-1161. doi: 10.1007/s11912-022-01273-5. Epub 2022 Apr 14. Curr Oncol Rep. 2022. PMID: 35420396 Free PMC article. Review.
-
A hybrid epithelial/mesenchymal state in head and neck cancer: A biomarker for survival with differential prognosis by self-reported race.Med. 2024 Jul 12;5(7):826-831.e3. doi: 10.1016/j.medj.2024.05.014. Epub 2024 Jun 19. Med. 2024. PMID: 38901426 Free PMC article.
-
Racial survival disparities in head and neck cancer clinical trials.J Natl Cancer Inst. 2023 Mar 9;115(3):288-294. doi: 10.1093/jnci/djac219. J Natl Cancer Inst. 2023. PMID: 36477855 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2019;69:7-34.
-
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
-
- Iyer NG, Tan DS, Tan VK, et al. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis. Cancer. 2015;121:1599-1607.
-
- Chinn SB, Spector ME, Bellile EL, et al. Efficacy of induction selection chemotherapy versus primary surgery for patients with advanced oral cavity carcinoma. JAMA Otolaryngol Head Neck Surg. 2014;140:134-142.
-
- Lewis CM, Ajmani GS, Kyrillos A, et al. Racial disparities in the choice of definitive treatment for squamous cell carcinoma of the oral cavity. Head Neck. 2018;40:2372-2382.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous